期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 23, 期 18, 页码 -出版社
MDPI
DOI: 10.3390/ijms231810885
关键词
amyloid-beta; neurodegenerative diseases; central nervous system (CNS); Alzheimer's disease; metal-organic framework; near-infrared phototherapy; brain-targeting; photo-oxygenation; porphyrinic nanoparticles
资金
- Hong Kong Research Grant Council Collaborative Research Fund [C5078-21EF]
- Innovation and Technology Fund, Guangdong-Hong Kong Cooperation Scheme [GHP/032/20SZ]
- Hong Kong Research Grant Council General Research Fund [PolyU 15210818, 15217621]
- Hong Kong Polytechnic University Internal Fund [1-ZVVQ]
This study introduces a novel approach for inhibiting amyloid aggregation through photothermally assisted photo-oxygenation treatment, achieving lower neurotoxicity and significant inhibition of Aβ aggregation.
Amyloid aggregation is associated with many neurodegenerative diseases such as Alzheimer's disease (AD). The current technologies using phototherapy for amyloid inhibition are usually photodynamic approaches based on evidence that reactive oxygen species can inhibit A beta aggregation. Herein, we report a novel combinational photothermally assisted photo-oxygenation treatment based on a nano-platform of the brain-targeting peptide RVG conjugated with the 2D porphyrinic PCN-222 metal-organic framework and indocyanine green (PCN-222@ICG@RVG) with enhanced photo-inhibition in Alzheimer's A beta aggregation. A photothermally assisted photo-oxygenation treatment based on PCN@ICG could largely enhance the photo-inhibition effect on A beta(42) aggregation and lead to much lower neurotoxicity upon near-infrared (NIR) irradiation at 808 nm compared with a single modality of photo-treatment in both cell-free and in vitro experiments. Generally, local photothermal heat increases the instability of A beta aggregates and keeps A beta in the status of monomers, which facilitates the photo-oxygenation process of generating oxidized A beta monomers with low aggregation capability. In addition, combined with the brain-targeting peptide RVG, the PCN-222@ICG@RVG nanoprobe shows high permeability of the human blood-brain barrier (BBB) on a human brain-on-achip platform. The ex vivo study also demonstrates that NIR-activated PCN-222@ICG@RVG could efficiently dissemble A beta plaques. Our work suggests that the combination of photothermal treatment with photo-oxygenation can synergistically enhance the inhibition of A beta aggregation, which may boost NIR-based combinational phototherapy of AD in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据